Financial Burden of Lymphedema Hospitalizations in the United States

Abstract

This cohort study uses data from the Healthcare Cost and Utilization Project Inpatient Sample to identify factors associated with high costs incurred during lymphedema-related hospitalizations in adults.

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure 1.. Association Between Factors and Extreme-Cost Hospitalizations

Extreme-cost hospitalizations were defined as those in the top 20th percentile (ie, ≥$10 893). Non-Hispanic (NH) other race/ethnicity included Asian or Pacific Islander, Native American, or other nonspecified race. Odds ratios were estimated using multivariable logistic regression and were adjusted for diagnosis site, age group, gender, race/ethnicity, insurance type, zip code income quartile, Charlson Comorbidity Index (CCI) score, hospital location and teaching status, hospital region, hospital size, and year of diagnosis.

Figure 2.. Association Between Patient, Disease, Hospital Characteristics, and Costs Treated as Continuous Variables

Relative differences were estimated using multivariable generalized gamma regression and were adjusted for diagnosis site, age group, gender, race/ethnicity, insurance type, zip code income quartile, Charlson Comorbidity Index (CCI) score, hospital location and teaching status, hospital region, hospital size, and year of diagnosis. IQR indicates interquartile range.